354
Views
5
CrossRef citations to date
0
Altmetric
Review

Safety of palliative chemotherapy in advanced pancreatic cancer

, , , &
Pages 947-954 | Received 28 Feb 2016, Accepted 08 Apr 2016, Published online: 03 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Suvina Amin, Seongjung Joo, Sandra Nolte, Hyun Kyoo Yoo, Nikunj Patel, Hilary F. Byrnes, Sara Costa-Cabral & Colin D. Johnson. (2022) Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values. BMC Cancer 22:1.
Crossref
Madhusudhan Alle, Garima Sharma, Seung-Hwan Lee & Jin-Chul Kim. (2022) Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives. Journal of Nanobiotechnology 20:1.
Crossref
C. Benedikt Westphalen, Tobias Kukiolka, Benjamin Garlipp, Lars Hahn, Martin Fuchs, Peter Malfertheiner, Marcel Reiser, Fabian Kütting, Volker Heinemann, Andreas Beringer & Dirk T. Waldschmidt. (2020) Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study. BMC Cancer 20:1.
Crossref
Bernhard W. Renz, Jan G. D'Haese & Jens Werner. (2019) Maligne Tumoren der Bauchspeicheldrüse. CME 16:10, pages 57-71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.